Literature DB >> 19388823

Low prevalence of drug resistance transmitted virus in HIV Type 1-infected ARV-naive patients in Cambodia.

Janin Nouhin1, Sopheak Ngin, P Regis Martin, Olivier Marcy, Leangsim Kruy, Frederic Ariey, Martine Peeters, Marie-Laure Chaix, Ahidjo Ayouba, Eric Nerrienet.   

Abstract

Abstract Between November 2006 and June 2007, HIV-1 reverse transcriptase (RT) and protease (PR) genes of 67 ARV-naive Cambodian patients were amplified and sequenced. At inclusion, the median age and duration of HIV infection were 28 and 1.1 years, respectively. The median CD4 and HIV-1 RNA were 611 cells/ml [IQR: 525-759] and 4.0 log(10) copies/ml [IQR: 3.4-4.6]. Among 67 HIV-1 strains, 95.5% were CRF 01_AE viruses (n = 64) whereas three clustered with subtype B. RT analysis indicated that only 1 patient out of 67, presenting K103N and M184V mutations, was resistant to NVP/EFV and 3TC/FTC. No primary resistance to protease inhibitors was detected in 59 amplified protease genes. The 1.49% (IC 95%: 0.04-8.04%) prevalence of transmitted drug-resistant strains in drug-naive patients was low in our study. Surveys of drug-resistant transmitted viruses should be regularly performed regarding the increasing access to HAART in Cambodia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19388823     DOI: 10.1089/aid.2008.0305

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions.

Authors:  James I Brooks; Harrison Niznick; Marianna Ofner; Harriet Merks; Jonathan B Angel
Journal:  BMC Infect Dis       Date:  2013-10-30       Impact factor: 3.090

2.  Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia.

Authors:  Hubert Barennes; Stéphanie Guillet; Setha Limsreng; Sovanvatey Him; Janin Nouhin; Chanroeurn Hak; Chanvatey Srun; Gerald Viretto; Vara Ouk; Jean Francois Delfraissy; Olivier Ségéral
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

3.  HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo.

Authors:  Fabien Roch Niama; Nicole Vidal; Halimatou Diop-Ndiaye; Etienne Nguimbi; Gabriel Ahombo; Philippe Diakabana; Édith Sophie Bayonne Kombo; Pembe Issamou Mayengue; Simon-Charles Kobawila; Henri Joseph Parra; Coumba Toure-Kane
Journal:  BMC Res Notes       Date:  2017-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.